NO20076186L - Mitotiske kinesininhibitorer og fremgangsmater for anvendelse derav - Google Patents
Mitotiske kinesininhibitorer og fremgangsmater for anvendelse deravInfo
- Publication number
- NO20076186L NO20076186L NO20076186A NO20076186A NO20076186L NO 20076186 L NO20076186 L NO 20076186L NO 20076186 A NO20076186 A NO 20076186A NO 20076186 A NO20076186 A NO 20076186A NO 20076186 L NO20076186 L NO 20076186L
- Authority
- NO
- Norway
- Prior art keywords
- methods
- inhibitors
- mitotic kinesin
- kinesin inhibitors
- pharmaceutical compositions
- Prior art date
Links
- 239000003112 inhibitor Substances 0.000 title abstract 5
- 238000000034 method Methods 0.000 title abstract 3
- 102000010638 Kinesin Human genes 0.000 title abstract 2
- 108010063296 Kinesin Proteins 0.000 title abstract 2
- 230000000394 mitotic effect Effects 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/12—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D419/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms
- C07D419/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D419/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D497/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms
- C07D497/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D497/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6536—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and sulfur atoms with or without oxygen atoms, as the only ring hetero atoms
- C07F9/6539—Five-membered rings
- C07F9/65392—Five-membered rings containing two nitrogen atoms
- C07F9/65395—Five-membered rings containing two nitrogen atoms having the two nitrogen atoms in positions 1 and 2
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Plural Heterocyclic Compounds (AREA)
- Fertilizers (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US67689005P | 2005-05-02 | 2005-05-02 | |
PCT/US2006/016526 WO2006119146A1 (en) | 2005-05-02 | 2006-05-01 | Mitotic kinesin inhibitors and methods of use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20076186L true NO20076186L (no) | 2008-02-01 |
Family
ID=37308299
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20076186A NO20076186L (no) | 2005-05-02 | 2007-11-30 | Mitotiske kinesininhibitorer og fremgangsmater for anvendelse derav |
Country Status (17)
Country | Link |
---|---|
US (5) | US7795282B2 (xx) |
EP (1) | EP1879886B1 (xx) |
JP (1) | JP2008540418A (xx) |
KR (1) | KR101329901B1 (xx) |
CN (1) | CN101248068A (xx) |
AU (1) | AU2006242380A1 (xx) |
BR (1) | BRPI0610193A2 (xx) |
CA (1) | CA2606708C (xx) |
HK (1) | HK1115376A1 (xx) |
IL (1) | IL186707A (xx) |
MX (1) | MX2007013539A (xx) |
NO (1) | NO20076186L (xx) |
RU (1) | RU2007144612A (xx) |
TW (1) | TW200716153A (xx) |
UA (1) | UA95907C2 (xx) |
WO (1) | WO2006119146A1 (xx) |
ZA (1) | ZA200710218B (xx) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7449486B2 (en) | 2004-10-19 | 2008-11-11 | Array Biopharma Inc. | Mitotic kinesin inhibitors and methods of use thereof |
UA95907C2 (xx) * | 2005-05-02 | 2011-09-26 | Эррей Биофарма Инк. | Інгібітори мітотичних кінезинів та їх використання$ингибиторы митотических кинезинов и их использование |
PE20091349A1 (es) * | 2007-10-19 | 2009-09-07 | Schering Corp | Compuestos derivados de espiro 1,3,4-tiadiazol como inhibidores de la actividad quinesina ksp |
US9561214B2 (en) * | 2008-10-16 | 2017-02-07 | Array Biopharma Inc. | Method of treatment using inhibitors of mitosis |
DE102009058280A1 (de) * | 2009-12-14 | 2011-06-16 | Merck Patent Gmbh | Thiazolderivate |
EP2455456A1 (en) | 2010-11-22 | 2012-05-23 | Institut Curie | Use of kinesin inhibitors in HIV infection treatment and a method for screening them |
EP3230259B1 (en) | 2014-12-08 | 2024-04-03 | The Research Foundation for The State University of New York | Anti-fungals targeting the synthesis of fungal shingolipids |
US11414378B2 (en) | 2017-06-16 | 2022-08-16 | The Research Foundation For The State University Of New York | Anti-fungals compounds targeting the synthesis of fungal sphingolipids |
KR20230049675A (ko) * | 2020-08-07 | 2023-04-13 | 이탈파마코 에스.피.에이. | 신규한 옥사디아졸-기반 선택적 hdac6 억제제 |
CN114014824B (zh) * | 2020-12-09 | 2023-06-13 | 上海科技大学 | 一种杂环化合物的应用 |
Family Cites Families (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2702803A (en) * | 1954-04-12 | 1955-02-22 | Lilly Co Eli | Substituted heterodiazoles |
ATE72431T1 (de) * | 1985-08-31 | 1992-02-15 | Fisons Plc | 5-gliedrige heterocyclische angiotensinumwandlungsenzym-inhibitoren. |
GB8625774D0 (en) * | 1986-10-28 | 1986-12-03 | Reckitt & Colmann Prod Ltd | Thiadiazole derivative |
JPH0572686A (ja) | 1991-09-11 | 1993-03-26 | Konica Corp | ハロゲン化銀写真感光材料 |
AU4288293A (en) * | 1992-04-27 | 1993-11-29 | E.I. Du Pont De Nemours And Company | Fungicidal 1,3,4-oxadiazines and 1,3,4-thiadiazines |
US6159938A (en) * | 1994-11-21 | 2000-12-12 | Cortech, Inc. | Serine protease inhibitors comprising α-keto heterocycles |
JPH10513443A (ja) * | 1995-02-02 | 1998-12-22 | スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー | 5HT▲下2c▼レセプターアンタゴニスト活性を有する複素環化合物 |
US5958957A (en) * | 1996-04-19 | 1999-09-28 | Novo Nordisk A/S | Modulators of molecules with phosphotyrosine recognition units |
US5668159A (en) * | 1996-05-08 | 1997-09-16 | The Dupont Merck Pharmaceutical Company | 1,3,4-thiadiazoles and 1,3,4-oxadiazoles as IIb/IIIa antagonists |
AR011164A1 (es) | 1997-02-28 | 2000-08-02 | Lilly Co Eli | Compuestos heterociclicos, composiciones farmaceuticas que los comprenden, y metodos para inhibir la liberacion del peptido beta-amiloide y/o su sintesismediante el uso de dichos compuestos |
ATE260904T1 (de) * | 1997-12-16 | 2004-03-15 | Warner Lambert Co | ((cyclo)alkyl substituierte)-.gamma.- aminobuttersäure derivate (=gaba analoga), deren herstellung und deren verwendung bei der behandlung von neurologischen erkrankungen |
JP2000159756A (ja) | 1998-11-23 | 2000-06-13 | American Cyanamid Co | 2―アリ―ル―δ2―1,3,4―(オキサおよびチア)ジアゾリン殺虫および殺ダニ剤 |
US6235762B1 (en) * | 1998-11-23 | 2001-05-22 | American Cyanamid Company | 2-aryl-Δ2-1,3,4-(oxa and thia)diazoline insecticidal and acaricidal agents |
US6277873B1 (en) * | 1999-03-25 | 2001-08-21 | Dingwei Tim Yu | Oxadiazole antifungal agents |
AU2001234741A1 (en) | 2000-02-04 | 2001-08-14 | Biogen, Inc. | Integrin antagonists |
WO2003018008A1 (fr) * | 2000-02-25 | 2003-03-06 | Shionogi & Co., Ltd. | Agent d'accélération de l'expression de apo ai |
US6284480B1 (en) | 2000-04-03 | 2001-09-04 | Cytokinetics, Inc. | Antifungal assay |
WO2003035512A1 (en) * | 2001-10-22 | 2003-05-01 | Outside In | Self dispensing cigarette pack |
PT1454903E (pt) * | 2001-12-11 | 2010-11-09 | Kyowa Hakko Kirin Co Ltd | Derivados de tiadiazolina para tratamento do cancro |
CA2478068C (en) * | 2002-03-08 | 2011-02-08 | Merck & Co., Inc. | Dihydropyrazole compounds useful for treating or preventing cancer |
US20050004186A1 (en) * | 2002-12-20 | 2005-01-06 | Pfizer Inc | MEK inhibiting compounds |
US20040167188A1 (en) * | 2003-02-14 | 2004-08-26 | Zhili Xin | Protein-tyrosine phosphatase inhibitors and uses thereof |
CA2517517C (en) | 2003-03-03 | 2012-12-18 | Array Biopharma, Inc. | P38 inhibitors and methods of use thereof |
EP1616866B1 (en) | 2003-04-18 | 2011-12-14 | Kyowa Hakko Kirin Co., Ltd. | M-stage kinesin inhibitor |
US7326790B2 (en) * | 2003-05-02 | 2008-02-05 | Rigel Pharmaceuticals, Inc. | Diphenylisoxazole compounds and hydro isomers thereof |
WO2004099164A1 (en) * | 2003-05-02 | 2004-11-18 | Rigel Pharmaceuticals, Inc. | Substituted diphenyl isoxazoles, pyrazoles and oxadiazoles useful for treating hcv infection |
US20050075375A1 (en) * | 2003-05-14 | 2005-04-07 | Anadys Pharmaceuticals, Inc. | Heterocyclic compounds for treating hepatitis C virus |
BRPI0410348A (pt) * | 2003-05-14 | 2006-05-30 | Torreypines Therapeutics Inc | compostos e usos dos mesmos na modulação de amilóide-beta |
WO2005000308A2 (en) * | 2003-05-15 | 2005-01-06 | Rigel Pharmaceuticals, Inc. | Methods of identifying hcv ns5b polymerase inhibitors and use against hepatitis c |
US7220745B2 (en) * | 2003-05-15 | 2007-05-22 | Rigel Pharmaceuticals | Heterocyclic compounds useful to treat HCV |
AU2004247551A1 (en) * | 2003-06-10 | 2004-12-23 | Fuji Photo Film Co., Ltd. | Thiadiazoline derivative |
WO2004111023A1 (ja) | 2003-06-10 | 2004-12-23 | Kyowa Hakko Kogyo Co., Ltd. | チアジアゾリン-1-オキシド誘導体 |
EP1656133A4 (en) | 2003-08-15 | 2008-10-29 | Merck & Co Inc | INHIBITORS OF MITOTIC KINESINE |
EP1671957A4 (en) * | 2003-10-10 | 2007-03-14 | THIADIAZOLINDERIVATE | |
JP2005232016A (ja) | 2004-02-17 | 2005-09-02 | Kyowa Hakko Kogyo Co Ltd | オキサジアゾリン誘導体 |
GB0406867D0 (en) | 2004-03-26 | 2004-04-28 | F2G Ltd | Antifungal agents |
AU2005285422A1 (en) | 2004-08-18 | 2006-03-23 | Merck Sharp & Dohme Corp. | Mitotic kinesin inhibitors |
US7449486B2 (en) | 2004-10-19 | 2008-11-11 | Array Biopharma Inc. | Mitotic kinesin inhibitors and methods of use thereof |
BRPI0517614A (pt) * | 2004-11-10 | 2008-10-14 | Basf Ag | métodos para regeneração de catalisador e para preparação de sais hidroxilamÈnio |
UA95907C2 (xx) | 2005-05-02 | 2011-09-26 | Эррей Биофарма Инк. | Інгібітори мітотичних кінезинів та їх використання$ингибиторы митотических кинезинов и их использование |
CN101553476A (zh) | 2006-10-03 | 2009-10-07 | 阵列生物制药公司 | 作为有丝分裂驱动蛋白抑制剂的二唑和噻二唑衍生物及其使用方法 |
US10174390B2 (en) | 2006-10-03 | 2019-01-08 | Gary M. Cola, JR. | Microtreatment of iron-based alloy, apparatus and method therefor, and articles resulting therefrom |
-
2006
- 2006-01-05 UA UAA200713355A patent/UA95907C2/ru unknown
- 2006-05-01 BR BRPI0610193-3A patent/BRPI0610193A2/pt not_active IP Right Cessation
- 2006-05-01 US US11/415,455 patent/US7795282B2/en not_active Expired - Fee Related
- 2006-05-01 WO PCT/US2006/016526 patent/WO2006119146A1/en active Application Filing
- 2006-05-01 RU RU2007144612/04A patent/RU2007144612A/ru not_active Application Discontinuation
- 2006-05-01 CN CNA2006800242288A patent/CN101248068A/zh active Pending
- 2006-05-01 JP JP2008510090A patent/JP2008540418A/ja active Pending
- 2006-05-01 CA CA2606708A patent/CA2606708C/en not_active Expired - Fee Related
- 2006-05-01 MX MX2007013539A patent/MX2007013539A/es not_active Application Discontinuation
- 2006-05-01 KR KR1020077027972A patent/KR101329901B1/ko active IP Right Grant
- 2006-05-01 EP EP06758821.0A patent/EP1879886B1/en active Active
- 2006-05-01 AU AU2006242380A patent/AU2006242380A1/en not_active Abandoned
- 2006-05-02 TW TW095115570A patent/TW200716153A/zh unknown
-
2007
- 2007-10-17 IL IL186707A patent/IL186707A/en active IP Right Grant
- 2007-11-27 ZA ZA200710218A patent/ZA200710218B/xx unknown
- 2007-11-30 NO NO20076186A patent/NO20076186L/no not_active Application Discontinuation
-
2008
- 2008-05-15 HK HK08105389.0A patent/HK1115376A1/xx not_active IP Right Cessation
-
2010
- 2010-06-23 US US12/822,066 patent/US8268871B2/en not_active Expired - Fee Related
-
2012
- 2012-08-15 US US13/586,355 patent/US8580828B2/en active Active
-
2013
- 2013-09-19 US US14/031,958 patent/US20140018399A1/en not_active Abandoned
-
2015
- 2015-03-19 US US14/663,286 patent/US9221841B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
RU2007144612A (ru) | 2009-06-10 |
CA2606708A1 (en) | 2006-11-09 |
HK1115376A1 (en) | 2008-11-28 |
US20130109656A1 (en) | 2013-05-02 |
CA2606708C (en) | 2015-01-06 |
JP2008540418A (ja) | 2008-11-20 |
IL186707A (en) | 2013-04-30 |
TW200716153A (en) | 2007-05-01 |
US20140018399A1 (en) | 2014-01-16 |
ZA200710218B (en) | 2009-07-29 |
CN101248068A (zh) | 2008-08-20 |
EP1879886A1 (en) | 2008-01-23 |
BRPI0610193A2 (pt) | 2010-06-01 |
US20100331283A1 (en) | 2010-12-30 |
EP1879886B1 (en) | 2014-07-09 |
US20060247178A1 (en) | 2006-11-02 |
WO2006119146A1 (en) | 2006-11-09 |
UA95907C2 (xx) | 2011-09-26 |
KR20080003934A (ko) | 2008-01-08 |
US20150191490A1 (en) | 2015-07-09 |
IL186707A0 (en) | 2008-02-09 |
EP1879886A4 (en) | 2010-09-08 |
US9221841B2 (en) | 2015-12-29 |
AU2006242380A2 (en) | 2008-07-03 |
US8580828B2 (en) | 2013-11-12 |
US8268871B2 (en) | 2012-09-18 |
US7795282B2 (en) | 2010-09-14 |
MX2007013539A (es) | 2008-01-24 |
AU2006242380A1 (en) | 2006-11-09 |
KR101329901B1 (ko) | 2013-11-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20072558L (no) | Mitotiske kineseinhibitorer og fremgangsmater for anvendelse derav | |
NO20076186L (no) | Mitotiske kinesininhibitorer og fremgangsmater for anvendelse derav | |
NO20074431L (no) | Pyrrolopyrimidiner nyttige som proteinkinaseinhibitorer | |
NO20064976L (no) | Azanidoler som er nyttige som inhibitorer av rock og andre proteinkinaser | |
NO20082026L (no) | Deazapuriner som er nyttige som inhibitorer for Janus-kinaser | |
HK1113569A1 (en) | Pyrazolo | |
NO20090157L (no) | Tienpyrimidiner anvendelige som modulatorer av ionekanaler | |
MXPA06011327A (es) | Azaindoles utiles como inhibidores de jak y otras proteinas cinasas. | |
NO20084747L (no) | Tetrahydropteridiner anvendbare som inhibitorer av protein kinaser | |
MXPA06014510A (es) | Composiciones y metodos para tratar trastornos inflamatorios. | |
TW200633980A (en) | Pyridones useful as inhibitors of kinases | |
NO20076447L (no) | Bicykliske derivater som modulatorer av ionekanaler | |
NO20083501L (no) | Azaindoler som er anvendelige som inhibitorer for Janus-kinaser | |
NO20072567L (no) | Triazoler nyttige som proteinkinase-inhibitorer | |
MX2009006345A (es) | Compuestos utiles como inhibidores de proteina cinasa. | |
NO20065762L (no) | Prodroger av pyrrolypyrimidin-ERK-proteinkinaseinhibitorer. | |
MX2009010127A (es) | Compuestos utiles como inhibidores de janus cinasas. | |
TW200716561A (en) | P38 inhibitors and methods of use thereof | |
UA87494C2 (xx) | Азаіндоли як інгібітори кіназ януса (jak) та інших протеїнкіназ[азаиндолы как ингибиторы киназ януса (jak) и других протеинкиназ | |
WO2008042928A3 (en) | Oxadiazole and thiadiazole derivatives as mitotic kinesin inhibitors and methods of use thereof | |
TW200603791A (en) | Compounds and compositions as cathepsin S inhibitors | |
UA98926C2 (ru) | Ингибитор митотических кинезинов и его использование |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |